Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Study of the LUM Imaging System for Assisting Intraoperative Detection of Residual Cancer in the Tumor Bed of Female Patients With Breast Cancer

NCT03686215 is registered in ClinicalTrials.gov with Lumicell, Inc. as lead sponsor.

NCT NCT03686215
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03686215 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Study of the LUM Imaging System for Assisting Intraoperative Detection of Residual Cancer in the Tumor Bed of Female Patients With Breast Cancer
Lead sponsor
Lumicell, Inc.
Phase
Phase 3
Overall status
Completed
Start date
November 4, 2019
Completion date
May 4, 2022
Enrollment
406 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer